Article Information
History
- October 19, 2021.
Article Versions
- You are currently viewing Version 1 of this article (October 19, 2021 - 16:01).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yuri Milaneschi1,*,
- Matthias Arnold2,3,
- Gabi Kastenmüller2,4,
- Siamak Mahmoudian Dehkordi3,
- Ranga R. Krishnan5,
- Boadie W. Dunlop6,
- A. John Rush3,7,8,
- Brenda W. J. H. Penninx1,
- Rima Kaddurah-Daouk3,9,10,
- for the Mood Disorders Precision Medicine Consortium (MDPMC)
- 1Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC/Vrije Universiteit, Amsterdam, The Netherlands
- 2Institute of Computational Biology, Helmholtz Zentrum München – German Research Center for Environmental Health, Neuherberg, Germany
- 3Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
- 4German Center for Diabetes Research (DZD), Neuherberg, Germany
- 5Department of Psychiatry, Rush Medical College, Chicago, IL, USA
- 6Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
- 7Duke-National University of Singapore, Singapore
- 8Department of Psychiatry, Texas Tech University, Health Sciences Center, Permian Basin, TX USA
- 9Duke Institute of Brain Sciences, Duke University, Durham, USA
- 10Department of Medicine, Duke University, Durham, USA
- ↵*Corresponding author
: Yuri Milaneschi, Department of Psychiatry, Amsterdam UMC, Vrije Universiteit/GGZ inGeest, Amsterdam, the Netherland, Oldenaller 1, 1081 HL Amsterdam, The Netherlands. Phone: (+)31-(0)20-7884682; Email: y.milaneschi{at}ggzingeest.nl
Posted October 19, 2021.
Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression
